Peer Support Program in Chronic Kidney Patient

NCT ID: NCT06555718

Last Updated: 2024-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-11

Study Completion Date

2025-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main advantage of patient-to-patient peer counseling is that it benefits both the client and the peer mentors as real and authentic experiences are shared. Since both individuals go through similar experiences, they can share common feelings. Although there are studies in the literature showing the effectiveness of peer support groups in different patient groups, studies on chronic kidney disease patients are limited. There are no studies on the effects of these programs on caregivers. This study will be conducted to examine the effects of peer support program applied to chronic kidney patients on patient outcomes and caregivers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was planned to be conducted with a randomized controlled experimental design to examine the effect of the peer support program applied to Chronic Kidney patients on patient outcomes and caregivers.

Patients diagnosed with Chronic Kidney Disease and receiving haemodialysis (HD) as a renal replacement method constitute the population of the study. In the a priori power analysis performed to calculate the number of subjects, the effect size was taken as 1.3 (d) based on reference studies. Accordingly, it was found that 34 subjects should be included in the calculation for the independent two-sample t-test according to 0.95 power and 0.05 alpha. The sample of the study will consist of 25 intervention and 25 control CKDs who fulfil the inclusion criteria, taking into account the dropout status.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peer Review Hemodialysis Complication Nurse's Role Health-Related Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study will start after obtaining official institutional permissions. The researcher will examine the profile of patients receiving treatment at the dialysis center. After this stage, the following steps will be followed
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
Intervation group (Peer support) Control group (Standart care)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group (Peer support)

"Peer mentors" will be determined among the participant patients in accordance with the peer mentor guide selection criteria.

The determined peer mentors will participate in the "Peer Mentor Training Programme".

Implementation of the research; Peer support programme for the intervention group will be carried out for 10 weeks in accordance with the peer guide-client implementation plan Standard follow-up and training programme will be applied to the control group in accordance with the procedures of the institution.

The data collection forms used in the research process will be collected at the stages specified in the study flow plan and data entry will be made by the researcher.

Group Type OTHER

The Peer Support Program

Intervention Type BEHAVIORAL

Implementation of the research; Peer support programme for the intervention group will be carried out for 10 weeks in accordance with the peer guide-client implementation plan. Standard follow-up and training programme will be applied to the control group in accordance with the procedures of the institution.

Control group (Standart care)

No intervention will be made by the researcher to the control group. The standard care of the institution will be applied to the patients.

Group Type OTHER

Standart care

Intervention Type BEHAVIORAL

The standard care provided by the institution will continue.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The Peer Support Program

Implementation of the research; Peer support programme for the intervention group will be carried out for 10 weeks in accordance with the peer guide-client implementation plan. Standard follow-up and training programme will be applied to the control group in accordance with the procedures of the institution.

Intervention Type BEHAVIORAL

Standart care

The standard care provided by the institution will continue.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Speaking Turkish
* To be literate
* CKD receiving haemodialysis
* Volunteering
* 18 years of age or older
* Being open to communication and co-operation
* Not having any psychiatric disorder


* Speaking Turkish
* To be literate
* CKD receiving haemodialysis
* Volunteering
* 18 years of age or older
* Not having any psychiatric disorder

Exclusion Criteria

* Being under 18 years of age
* Speaking a language other than Turkish
* Not being able to use a telephone

Losses to follow-up

* Experiencing incompatibility with the second peer mentor or client with whom they are paired for peer mentor and peer client
* Death during the period of intervention or follow-up
* Withdrawal of patient consent
* Clinical problems or difficulties attending appointments that hinder follow-up
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Acibadem University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Canan Yüksel Acar, Msc

Role: PRINCIPAL_INVESTIGATOR

Acibadem Universty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Canan Yüksel Acar

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ATADEK2023-21/765

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Educational Intervention and Adherence
NCT06742827 ACTIVE_NOT_RECRUITING NA